Cardiometabolic News and Research

RSS

Sedentary behaviour worsens health of heart disease patients

Patients with heart disease who sit a lot have worse health even if they exercise, reveals research from the University of Ottawa Heart Institute, and published today in the European Journal of Cardiovascular Prevention.

26 Nov 2015

Myriad RBM's DiscoveryMAP platform identifies protein biomarkers linked to CV events in diabetes patients

Myriad RBM, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced that its DiscoveryMAP platform successfully identified combinations of 15 protein biomarkers associated with cardiovascular (CV) events or death in people with pre-diabetes or early type 2 diabetes, according to a study published by the journal Circulation.

17 Nov 2015

CV risk assessment essential for CML TKI trial design

The risk and impact of cardiovascular adverse events in long-term users of tyrosine kinase inhibitors for chronic myeloid leukaemia is highlighted in a review published in the Journal of Clinical Oncology.

22 Oct 2015

FENS satellite symposium to highlight health benefits of regular fat dairy foods

The 12th FENS European Nutrition Conference will take place in Berlin, Germany from 20th to 23rd October 2015 and gather leading nutrition experts from around the world to discuss the latest developments in nutrition research. In conjunction with the conference, on 21st October a satellite symposium on "Regular Fat Dairy Foods in Nutrition and Health: The Latest insights" will present an update on the benefits.

1 Oct 2015

Severely obese children face higher risk of developing heart disease, diabetes

A new study led by researchers in the UNC Department of Pediatrics finds a direct correlation between more severe forms of obesity in children and related risk factors for developing heart disease and diabetes—particularly in boys.

1 Oct 2015

New research enables ‘tailored’ diet advice based on personal gut microbiome

New research enables "tailored" diet advice - based on our personal gut microbiome - for persons who want to lose weight and reduce the risk of disease.

10 Sep 2015

Reducing SSB intake among children and adolescents associated with greater increase in HDL-C

In the first study to investigate blood lipid levels in association with consumption of sugar-sweetened beverages (SSBs) in a racially and ethnically diverse sample of Boston area schoolchildren, researchers found there was an inverse association between SSB intake changes and HDL-cholesterol increases (HDL-C is the "good cholesterol").

3 Sep 2015

Liraglutide drug combined with diet and exercise promotes weight loss in diabetic patients

Among overweight and obese patients with type 2 diabetes, daily injection of the diabetes drug liraglutide with a modified insulin pen device, in addition to diet and exercise, resulted in greater weight loss over 56 weeks compared with placebo, according to a study in the August 18 issue of JAMA.

19 Aug 2015

Leading researchers, policymakers and health professionals to discuss on obesity, weight loss at ObesityWeek 2015

More than 1,500 research abstracts will be presented on new and emerging obesity treatments, the science of weight loss, new prevention strategies, metabolic surgery, digital health technology and public policy, when thousands of leading researchers, policymakers and health professionals gather for ObesityWeek 2015 at the Los Angeles Convention Center in California from November 2 to 7, 2015.

11 Aug 2015

Resverlogix announces formation of international Clinical Steering Committee for RVX-208 "apabetalone" Phase 3 trial

Resverlogix Corp. is pleased to announce the formation of an international Clinical Steering Committee for the RVX-208 "apabetalone" Phase 3 clinical trial BETonMACE assessing major adverse cardiac events (MACE) in high-risk vascular patients with diabetes mellitus and a recent Acute Coronary Syndrome event. BETonMACE is expected to start in the fall of 2015.

4 Aug 2015

NEJM publishes positive clinical results from Phase 2 clinical study of volanesorsen

Isis Pharmaceuticals, Inc., the leader in RNA-targeted therapeutics, and Akcea Therapeutics, its wholly owned subsidiary, announced today that The New England Journal of Medicine (NEJM) has published positive clinical results from a Phase 2 clinical study evaluating volanesorsen (formerly ISIS-APOCIII Rx) in patients with very high to severely high triglycerides.

30 Jul 2015

Virginia Tech researchers develop new scoring method for assessing overall beverage intake quality

Researchers at Virginia Tech have developed a new scoring method for assessing beverage intake, the Healthy Beverage Index (HBI). In a report published in the Journal of the Academy of Nutrition and Dietetics they describe how this tool can be used to more accurately evaluate dietary consumption of all types of fluids.

10 Jul 2015

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Akcea Therapeutics, a wholly-owned subsidiary of Isis Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation to volanesorsen (ISIS-APOCIIIRx) for the treatment of patients with Familial Chylomicronemia Syndrome (FCS).

6 Jul 2015

Researchers analyze cardiometabolic benefits of exercise

Everyone knows that exercise generally helps the cardiovascular system, but much remains unknown about how the benefits arise, and what to expect in different people who exercise to improve their health. To gain a more precise understanding of how exercise improves health and whom it helps most, researchers analyzed the results of 160 randomized clinical trials with nearly 7,500 participants.

3 Jul 2015

Drinking low-calorie cranberry juice may help lower risk of heart disease, diabetes and stroke

A new study reveals that drinking low-calorie cranberry juice cocktail may help lower the risk of chronic diseases that rank among the leading causes of death worldwide, including heart disease, diabetes and stroke. The finding is welcome news considering the World Health Organization estimates the trio of diseases annually claim 15.6 million lives around the globe.

30 Jun 2015

MHICN expands clinical research program in collaboration with Erasmus Medical Center and ErasmusAGE

Metagenics Healthcare Institute for Clinical Nutrition announced today an expanded clinical research program in collaboration with Erasmus Medical Center and ErasmusAGE, from Rotterdam, the Netherlands – a leading global healthcare center in epidemiology and health outcomes research.

1 Jun 2015

Cardiometabolic News and Research

Sedentary behaviour worsens health of heart disease patients

Myriad RBM's DiscoveryMAP platform identifies protein biomarkers linked to CV events in diabetes patients

CV risk assessment essential for CML TKI trial design

FENS satellite symposium to highlight health benefits of regular fat dairy foods

Severely obese children face higher risk of developing heart disease, diabetes

New research enables ‘tailored’ diet advice based on personal gut microbiome

Reducing SSB intake among children and adolescents associated with greater increase in HDL-C

Liraglutide drug combined with diet and exercise promotes weight loss in diabetic patients

Leading researchers, policymakers and health professionals to discuss on obesity, weight loss at ObesityWeek 2015

Resverlogix announces formation of international Clinical Steering Committee for RVX-208 "apabetalone" Phase 3 trial

NEJM publishes positive clinical results from Phase 2 clinical study of volanesorsen

Virginia Tech researchers develop new scoring method for assessing overall beverage intake quality

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Researchers analyze cardiometabolic benefits of exercise

Drinking low-calorie cranberry juice may help lower risk of heart disease, diabetes and stroke

MHICN expands clinical research program in collaboration with Erasmus Medical Center and ErasmusAGE

Boehringer Ingelheim, University of Michigan partner to discover new medicines for diabetic nephropathy

Accelerated brain aging related to cognitive complications observed in people with type 1 diabetes

Study: Cardiorespiratory fitness associated with reduced metabolic syndrome risk among smokers

CVD risk assessment still important in severely obese adolescents

Advances in cardiometabolic research and clinical trial design eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News